menu
    • menu

    Company profile for Ionetix

    NEW Drugs in Dev: 1
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Founded in 2009 from technology born at MIT Plasma Science and Fusion Center, IONETIX developed the world’s first commercial compact superconducting cyclotron, the ION-12SC used to produce N-13 Ammonia, one of the most accurate PET imaging agents for the detection of CAD.IONETIX is actively establishing a network of ION-12SCs installed on or near the campus of PET programs across the country.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IonetixUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    101 The Embarcadero Suite 210 San Francisco, CA 94105
    Telephone
    Telephone
    (517) 252-4069
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.ionetix.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ionetix Gets ANDA Approval for Ga-68 Gozetotide (PSMA-11)
    Ionetix Gets ANDA Approval for Ga-68 Gozetotide (PSMA-11)

    26 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/26/3301225/0/en/ionetix-announces-approval-of-abbreviated-new-drug-application-for-gallium-ga-68-gozetotide-psma-11.html

    GLOBENEWSWIRE
    26 May 2026
    Share Share
    Ionetix’s Generics Gallium Gozetotide Receives Approval in US
    Ionetix’s Generics Gallium Gozetotide Receives Approval in US

    14 May 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219189

    FDA
    14 May 2026
    Share Share
    AtomVie Secures Ac-225 Supply from Ionetix to Advance Radiopharma
    AtomVie Secures Ac-225 Supply from Ionetix to Advance Radiopharma

    18 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/atomvie-global-radiopharma-secures-a-supply-agreement-with-ionetix-corporation-to-accelerate-ac-225-radiotherapeutics-development-302645520.html

    PR NEWSWIRE
    18 Dec 2025
    Share Share
    Cellectar Bio Inks Actinium-225 Deal With Ionetix
    Cellectar Bio Inks Actinium-225 Deal With Ionetix

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206203/29076/en/Cellectar-Biosciences-Announces-Strategic-Supply-Agreement-with-Ionetix-for-Actinium-225-and-Astatine-211-to-Advance-Targeted-Alpha-Therapies.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    NAYA and IONETIX to Build US Network for Astatine-211 Therapies
    NAYA and IONETIX to Build US Network for Astatine-211 Therapies

    21 Aug 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/biotechnology/naya-therapeutics-partners-with-ionetix-to-build-a-us-production-and-supply-network-f-1063771

    ACCESSWIRE
    21 Aug 2025
    Share Share
    IONETIX closes financing led by Tees River and Eli Lilly and Company
    IONETIX closes financing led by Tees River and Eli Lilly and Company

    07 Aug 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ionetix-closes-financing-led-by-tees-river-and-eli-lilly-and-company-302216675.html

    PR NEWSWIRE
    07 Aug 2024
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search